[1]李思思,杨金月,赵勇,等.基于CiteSpace的中医药治疗新型冠状病毒肺炎知识图谱分析[J].西部中医药,2022,35(05):9-12.[doi:10.12174/j.issn.2096-9600.2022.05.02]
　LI Sisi,YANG Jinyue,ZHAO Yong,et al.Analysis of Knowledge Map of TCM Therapy of COVID-19 Based on CiteSpace[J].Western Journal of Traditional Chinese Medicine,2022,35(05):9-12.[doi:10.12174/j.issn.2096-9600.2022.05.02]
点击复制

基于CiteSpace的中医药治疗新型冠状病毒肺炎知识图谱分析
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
35
期数:
2022年05期
页码:
9-12
栏目:
出版日期:
2022-05-15

文章信息/Info

Title:
Analysis of Knowledge Map of TCM Therapy of COVID-19 Based on CiteSpace
作者:
李思思1, 杨金月1, 赵勇2,3, 华川1,2,3, 左新河1,2,3
1.湖北中医药大学，湖北 武汉 430061
2.湖北省中医院甲状腺疾病诊疗中心
3.湖北省陈氏瘿病学术流派传承工作室
Author(s):
LI Sisi1, YANG Jinyue1, ZHAO Yong2,3, HUA Chuan1,2,3, ZUO Xinhe1,2,3
1.Hubei University of Chinese Medicine, Wuhan 430061, China
2.Thyroid Disease Diagnosis and Treatment Center, Hubei Provincial Hospital of TCM
3.Hubei Provincial Chen’s Inheritance Studio of Goiter Academic School
关键词:
新型冠状病毒肺炎; CiteSpace; 知识图谱; 中医药
Keywords:
COVID-19; CiteSpace; knowledge map; TCM
分类号:
R272
DOI:
10.12174/j.issn.2096-9600.2022.05.02
文献标志码:
A
摘要:
目的基于CiteSpace软件统计分析中医药治疗新型冠状病毒肺炎（Corona Virus Disease 2019，COVID-19）的研究热点、机构合作网络及作者合作网络。 方法检索2020年1月29日至2020年2月29日中国知网（CNKI）收录的中医药治疗COVID-19的相关研究文献，运用CiteSpace V5.6软件对数据进行统计分析并绘制相关图谱。 结果共检索到中医药治疗COVID-19的相关研究文献137篇；目前主要有治未病、瘥后防复、合理用药、中医治疗、中医药、治则治法、诊疗方案等7个研究热点；研究机构共60所，且机构间实现跨区域合作，形成4个主要研究团队。 结论中医药治疗COVID-19有其独特优势，但仍需要进一步深入研究。
Abstract:
ObjectiveTo statistically analyze research hot spots, institutional cooperation network and author collaboration network of TCM therapy of COVID-19 based on CiteSpace software. MethodsThe related papers about TCM therapy of COVID-19 were searched from CNKI from January 29, 2020 to February 29, 2020, CiteSpace V5.6 was used to statistically analyze the data and draw the related maps. ResultsThere were 137 papers related to TCM therapy of COVID-19, currently mainly seven research hotspots including preventive treatment of disease, prevention of the recurrence after the recovery, rational medication, TCM therapy, TCM, therapeutic principles and methods, diagnostic and therapeutic regimen, 60 research institutions, inter-institutional cooperation has been achieved across the regions, forming four main research teams. ConclusionTCM has its unique advantage in the treatment of COVID-19, while it needs to be further studied.

相似文献/References:

[1]李赟,王彩弟,王建云,等.简约远程中医诊疗在新型冠状病毒肺炎隔离病区中的应用[J].西部中医药,2020,33(S1):1.
　LI Yun,WANG Caidi,WANG Jianyun,et al.The Application of Simple Remote TCM Diagnosis and Treatment to COVID-19 Quarantined Inpatient Area[J].Western Journal of Traditional Chinese Medicine,2020,33(05):1.
[2]宋忠阳,雍文兴,张利英,等.新型冠状病毒肺炎的中医临床特征与辨证论治——甘肃经验*[J].西部中医药,2020,33(S1):3.
　SONG Zhongyang,YONG Wenxing,ZHANG Liying,et al.The Experience of TCM Clinical Characteristics, Syndrome Differentiation and Treatment for COVID-19 in Gansu Province[J].Western Journal of Traditional Chinese Medicine,2020,33(05):3.
[3]杜洪霖,马战平△.西北地区新型冠状病毒肺炎的中医特点及防治*[J].西部中医药,2020,33(S1):5.
　DU Honglin,MA Zhanping.TCM Characteristics, the Prevention and Treatment of COVID-19 in Northwest China[J].Western Journal of Traditional Chinese Medicine,2020,33(05):5.
[4]潘文,李盛华,王晓萍,等.中医对新型冠状病毒肺炎的认识与防治探讨[J].西部中医药,2020,33(S1):7.
　PAN Wen,LI Shenghua,WANG Xiaoping,et al.On TCM Understanding, the Prevention and Treatment of COVID-19[J].Western Journal of Traditional Chinese Medicine,2020,33(05):7.
[5]杨海侠,张银萍△,杨长虹,等.新型冠状病毒肺炎疑似患者留观隔离期的护理体会[J].西部中医药,2020,33(S1):13.
[6]丁潇,邹忆怀△,辛大永,等.北京顺义地区新型冠状病毒肺炎的中医临床证候与CT表现[J].西部中医药,2020,33(S1):16.
　DING Xiao,ZOU Yihuai,XIN Dayong,et al.TCM Clinical Syndromes and CT Manifestations of COVID-19 in Shunyi District of Beijing[J].Western Journal of Traditional Chinese Medicine,2020,33(05):16.
[7]桑天庆,周红光△.中医药在新型冠状病毒肺炎疫情中的应用[J].西部中医药,2020,33(S1):18.
　SANG Tianqing,ZHOU Hongguang.TCM Applied to Epidemic Situation of COVID-19[J].Western Journal of Traditional Chinese Medicine,2020,33(05):18.
[8]闫向勇,李 俊,燕忠生△.武汉地区新型冠状病毒肺炎中医证候及病机特点[J].西部中医药,2020,33(S1):20.
　YAN Xiangyong,LI Jun,YAN Zhongsheng.On the Characteristics of TCM Patterns and the Pathogenesis of COVID-19 in Wuhan Region[J].Western Journal of Traditional Chinese Medicine,2020,33(05):20.
[9]曾建峰,李乐愚,缪灿铭,等.岭南道地药材在中山地区新型冠状病毒肺炎防治中的应用*[J].西部中医药,2020,33(S1):24.[doi:10.1056/NEJMoa-2001017]
　and Treatment of COVID-9 in Zhongshan Region.The Application of Lingnan Genuine Drugs to the Prevention[J].Western Journal of Traditional Chinese Medicine,2020,33(05):24.[doi:10.1056/NEJMoa-2001017]
[10]朱玉,黎玉婷,姚德蛟△.从中西医不同角度分析麻杏石甘汤治疗新型冠状病毒肺炎的作用[J].西部中医药,2020,33(S1):26.
　of Traditional Chinese Medicine and Western Medicine.The Functions of Maxing Shigan Tang in the Treatment for COVID-19 from the Angles[J].Western Journal of Traditional Chinese Medicine,2020,33(05):26.

备注/Memo

备注/Memo:
李思思（1995—），女，硕士学位。研究方向：内分泌代谢及免疫性疾病的中医药防治。全国中医学术流派传承工作室第二轮建设项目〔国中医药人教函（2019）62号〕。
更新日期/Last Update: 2022-06-24